ltb4
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00251537)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Beta-lactamase Toho-1AGONIST
agonist - BLT1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leukotriene b4
- leukotriene b4
- leukotriene b4
- ltb4
- ltb4
- ltb4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03192280 | N/A | Jun 19, 2017 | Leo Pharma, Q-Pharm |
| NCT00251537 | Phase 2 | Nov 1, 2005 | LTB4 Sweden AB, McGill University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leo Pharma | For profit | 1 | 1 | 1 | 2017 |
| LTB4 Sweden AB | For profit | 1 | 1 | 1 | 2005 |
| McGill University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Q-Pharm | For profit | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1